Testing for anti-Müllerian hormone: analytical performances and usability of a point-of-care assay

Clin Chem Lab Med. 2022 Mar 23;60(6):e138-e141. doi: 10.1515/cclm-2022-0069. Print 2022 May 25.

Authors

Louise Guillaume¹, Virginie Chapelle¹, Carmen Minea², Damien Gruson^{1

3}

Affiliations

¹ Department of Clinical Biochemistry, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium.
² Department of Clinical Biochemistry, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
³ Pôle de recherche en Endocrinologie, Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium.

PMID: 35315982
DOI: 10.1515/cclm-2022-0069

No abstract available

Keywords: anti-Müllerian hormone (AMH); biomarker; infertility; ovarian; point-of-care.

Publication types

Letter

MeSH terms

Anti-Mullerian Hormone*
Biological Assay
Female
Humans
Ovarian Follicle
Point-of-Care Systems
Polycystic Ovary Syndrome*

Substances

Anti-Mullerian Hormone